T CELL-BASED METHODS FOR PREDICTING POLYPEPTIDE IMMUNOGENICITY Application WO-2022031948-A1 World Intellectual Property Organisation (WIPO) 10 Feb 2022
Methods for manufacturing activatable binding polypeptides comprising matrix… Grant US-11028162-B2 United States of America 08 Jun 2021
Methods of treatment using activatable anti-EGFR antibodies Grant US-10875913-B2 United States of America 29 Dec 2020
Activatable antibodies that bind epidermal growth factor receptor and methods of use… Grant US-10709799-B2 United States of America 14 Jul 2020
Antibodies that bind activatable antibodies and methods of use thereof Grant US-10568977-B2 United States of America 25 Feb 2020
Nucleic acids encoding activatable antibodies that bind epidermal growth factor receptor Grant US-10533053-B2 United States of America 14 Jan 2020
MODIFIED PROTEIN Application WO-2019138222-A1 World Intellectual Property Organisation (WIPO) 18 Jul 2019
Activatable binding polypeptides and methods of identification and use thereof Grant US-10077300-B2 United States of America 18 Sep 2018
Activatable antibodies that bind epidermal growth factor receptor and methods of use… Grant US-9889211-B2 United States of America 13 Feb 2018
Antibodies that bind activatable antibodies and methods of use thereof Grant US-9737623-B2 United States of America 22 Aug 2017
Activatable antibodies that bind epidermal growth factor receptor and methods of use… Grant US-9545442-B2 United States of America 17 Jan 2017
Activatable antibodies that bind epidermal growth factor receptor and methods of use… Grant US-9540440-B2 United States of America 10 Jan 2017
Modified antibody compositions, methods of making and using thereof Grant US-9453078-B2 United States of America 27 Sep 2016